Gusacitinib | Interleukin Related interleukin-related.com

Product Name :
Gusacitinib

Search keywords :
Gusacitinib

drugId :
null

Target Vo:
Janus kinase

Target Vo Short Name :
JAK

Moa_Name:
Spleen tyrosine kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Asana Biosciences Llc

Active Company_Name :
Asana Biosciences Llc

Active Indication_Name:
Dermatitis

In Active Indication_Name:
Lymphoma, B-Cell

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etesevimab Anti-infection
Otilimab In stock
FIP200 Antibody: FIP200 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to FIP200. It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts